Home LiteratureArticle Details
PMID: 1291082 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.

Cardiovascular research ·Vol. 26 ·No. 11 ·1992-11-00 ·Pages 1054-62

Auchampach JA, Grover GJ, Gross GJ

Abstract

The aims were: (1) to determine if a new ischaemia selective ATP dependent potassium (KATP) channel antagonist, sodium 5-hydroxydecanoate (5-HD), blocks ischaemic preconditioning in dogs; (2) to determine whether a small intracoronary dose of glibenclamide, a classical sulphonylurea KATP channel antagonist, could block ischaemic preconditioning independent of systemic metabolic effects. Barbitone anaesthetised dogs were subjected to 60 min of left circumflex coronary artery occlusion followed by 5 h of reperfusion. Preconditioning was produced by a single 5 min left circumflex occlusion followed by 10 min of reperfusion prior to the 60 min occlusion period. 5-HD (150 micrograms.kg-1 x min-1) or vehicle was given by intracoronary infusion into the ischaemic region over 20 min, beginning 15 min prior to the 60 min occlusion period in the presence or absence of preconditioning. Glibenclamide (3 micrograms.kg-1 x min-1) was given by intracoronary infusion into the left circumflex artery during the 5 min preconditioning period or during the first 5 min of occlusion in preconditioned or non-preconditioned dogs. Transmural myocardial blood flow was measured by radioactive microspheres and infarct size determined by triphenyltetrazolium staining and expressed as a percent of the area at risk. There were no differences in haemodynamic variables, myocardial blood flow, area at risk, or blood glucose between groups. Infarct size was markedly reduced in preconditioned dogs compared to control animals, at 7(SEM 2)% v 29(4)%, p < 0.05 The reduction in infarct size by preconditioning was blocked completely by intracoronary 5-HD, or by intracoronary glibenclamide given during preconditioning or during the first 5 min of the prolonged occlusion period. Neither 5-HD nor glibenclamide affected infarct size in the absence of preconditioning at the doses studied. These results further strengthen the hypothesis that activation of myocardial KATP channels is involved in the mechanism of ischaemic preconditioning in dogs.

MeSH Terms
Animals Benzopyrans/pharmacology Blood Glucose/metabolism Blood Pressure/drug effects Coronary Circulation/drug effects,physiology Coronary Vessels/physiology Decanoic Acids/pharmacology Dihydropyridines/pharmacology Dogs Glyburide/pharmacology Heart Rate/drug effects Hydroxy Acids/pharmacology Myocardial Ischemia/metabolism Myocardium/metabolism Potassium/antagonists & inhibitors Potassium Channels/metabolism Vasodilator Agents/pharmacology
Chemicals
Benzopyrans Blood Glucose Decanoic Acids Dihydropyridines Hydroxy Acids Potassium Channels Vasodilator Agents bimakalim 5-hydroxydecanoic acid Potassium Glyburide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Auchampach J A
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee 53226.
Grover G J
Gross G J
Article Info
Journal
Cardiovascular research
Abbr.
Cardiovasc Res
ISSN
0008-6363
Published
1992-11-00
Pages
1054-62
Language
English
Region
England
NLM ID
0077427
Subset
IM
Grants
NHLBI NIH HHS · HL 08311 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]